CompletedNCT01354470
Modafinil for Methamphetamine Use and Withdrawal
About this title
A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
Read the official source — NCT01354470Medication studyAges 18–50United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- Lafayette and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateOctober 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 72
- Sponsor
- California Pacific Medical Center Research Institute
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT01354470
- Official title
Show the full official title
A Randomized, Placebo-Controlled Trial of Modafinil for Methamphetamine Dependence
Get this study by email
Recruitment & locations
CompletedLafayette · San Francisco
Questions about this study
Who is behind this study?
The study sponsor is California Pacific Medical Center Research Institute, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Modafinil.
Who was this study for?
Listed age limits: 18 years to 50 years.
